Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ocugen Inc (NQ: OCGN )

1.479 +0.009 (+0.59%)
Streaming Delayed Price Updated: 10:38 AM EDT, Jul 31, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ocugen Inc

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
31 32 Next >
Ocugen to Participate in Panel at Cantor Fitzgerald Global Healthcare Conference 2023
From Ocugen
Via GlobeNewswire
Ocugen Announces Positive Clinical Study Update from the Phase 1/2 Trial of OCU400, a Modifier Gene Therapy Product Candidate, for the Treatment of Retinitis Pigmentosa (RP) and Leber Congenital Amaurosis (LCA)
From Ocugen
Via GlobeNewswire
Ocugen to Host Virtual Investor & Analyst Event on September 13, 2023
Company to share updated results from ongoing Phase 1/2 trial of OCU400 for the treatment of Retinitis Pigmentosa and Leber Congenital Amaurosis 
From Ocugen
Via GlobeNewswire
A Preview Of Ocugen's Earnings
Via Benzinga
Can Pat Toomey Save Ocugen (OCGN) Stock?
Shares of OCGN stock received a boost this morning following the addition of some high-profile names to Ocugen's advisory board. 
Via InvestorPlace
Ocugen (OCGN) Q2 2023 Earnings Call Transcript
OCGN earnings call for the period ending June 30, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Ocugen Provides Business Update with Second Quarter 2023 Financial Results
From Ocugen
Via GlobeNewswire
Ocugen to Host Conference Call on Tuesday, August 22 at 8:30 A.M. ET to Discuss Business Updates and Second Quarter 2023 Financial Results
From Ocugen
Via GlobeNewswire
3 Millionaire-Maker Growth Stocks to Buy Before the Window
Although millionaire-maker stocks to buy present wildly outrageous risks, the intrepid may find opportunity in these ideas. 
Via InvestorPlace
Ocugen (OCGN) Q1 2023 Earnings Call Transcript
OCGN earnings call for the period ending March 31, 2023. 
Via The Motley Fool
7 Biotech Stocks to Sell in July
Running the gamut from large to small, and from commercial stage to clinical stage, these are seven top biotech stocks to sell in July. 
Via InvestorPlace
7 Doomed Growth Stocks Destined for Disaster
Investing in growth stocks can be very expensive. Save yourself some time and money by avoiding these doomed growth stocks to sell. 
Via InvestorPlace
Ocugen CEO & CSO to Present at 41st Annual AAPI Convention and Scientific Assembly
From Ocugen
Via GlobeNewswire
Ocugen And 2 Other Stocks Under $2 Insiders Are Aggressively Buying
The Dow Jones closed lower by over 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested... 
Via Benzinga
Ocugen, Inc. Announces Adjournment of Annual Meeting of Shareholders
From Ocugen
Via GlobeNewswire
Ocugen, Inc. Announces Business Advisory Board
From Ocugen
Via GlobeNewswire
Wall Street Expects These Stocks to Soar 175% and 545%. Should You Buy?
These companies haven't given up on the coronavirus vaccine market. 
Via The Motley Fool
5 Investors Betting Big on Ocugen (OCGN) Stock Right Now
Ocugen has been falling after announcing a new share offering. But that's not the only reason hedge funds are moving away from OCGN stock. 
Via InvestorPlace
Crude Oil Rises 2%; Kohl's Reports Surprise Q1 Profit
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 250 points on Wednesday. The Dow traded down 0.73% to 32,813.21 while the NASDAQ fell 0.77% to 12,463.32. The S&P... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Nasdaq Down 1%; US Crude Oil Inventories Decline Last Week
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping over 100 points on Wednesday. The Dow traded down 0.72% to 32,816.38 while the NASDAQ fell 1.12% to 12,419.97. The... 
Via Benzinga
Why Is Apexigen (APGN) Stock Up 31% Today?
Apexigen (APGN) stock is rising higher on Wednesday following news of a $16 million acquisition deal with Pyxis Oncology (PYXS). 
Via InvestorPlace
Why Is Ocugen (OCGN) Stock Down 22% Today?
Ocugen (OCGN) stock is falling on Wednesday after the pharmaceutical company revealed details of a public offering for its shares. 
Via InvestorPlace
Why America's Car-Mart Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Minerva Surgical, Inc. (NASDAQ: UTRS) shares jumped 209.1% to $0.5622 after the United States Patent and Trademark Office granted the company a patent for certain medical systems and methods. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Ocugen, Inc. Announces Pricing of $16.5 Million Public Offering of Common Stock
From Ocugen
Via GlobeNewswire
Why Inovio Pharmaceuticals Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Gainers Minerva Surgical, Inc. (NASDAQ: UTRS) shares rose 202.3% to $0.5499 in pre-market trading. Minerva Surgical was granted U.S. Patent #11653972 for "Medical Systems And Methods (For Resecting And... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time for a dive into the biggest pre-market stock movers as we check out all of the latest news for Wednesday morning! 
Via InvestorPlace
Ocugen, Inc. Announces Proposed Public Offering of Common Stock
From Ocugen
Via GlobeNewswire
Ocugen to Present at BIO International Convention 2023
From Ocugen
Via GlobeNewswire
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
31 32 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.